University of Leicester
Browse

Isolation and Characterization of Klebsiella Phages for Phage Therapy

Download (1.46 MB)
journal contribution
posted on 2021-05-10, 15:58 authored by Eleanor M Townsend, Lucy Kelly, Lucy Gannon, George Muscatt, Rhys Dunstan, Slawomir Michniewski, Hari Sapkota, Saija J Kiljunen, Anna Kolsi, Mikael Skurnik, Trevor Lithgow, Andrew D Millard, Eleanor Jameson
Introduction: Klebsiella is a clinically important pathogen causing a variety of antimicrobial resistant infections in both community and nosocomial settings, particularly pneumonia, urinary tract infection, and sepsis. Bacteriophage (phage) therapy is being considered a primary option for the treatment of drug-resistant infections of these types.
Methods: We report the successful isolation and characterization of 30 novel, genetically diverse Klebsiella phages.
Results: The isolated phages span six different phage families and nine genera, representing both lysogenic and lytic lifestyles. Individual Klebsiella phage isolates infected up to 11 of the 18 Klebsiella capsule types tested, and all 18 capsule-types were infected by at least one of the phages.
Conclusions: Of the Klebsiella-infecting phages presented in this study, the lytic phages are most suitable for phage therapy, based on their broad host range, high virulence, short lysis period and given that they encode no known toxin or antimicrobial resistance genes. Phage isolates belonging to the Sugarlandvirus and Slopekvirus genera were deemed most suitable for phage therapy based on our characterization. Importantly, when applied alone, none of the characterized phages were able to suppress the growth of Klebsiella for more than 12 h, likely due to the inherent ease of Klebsiella to generate spontaneous phage-resistant mutants. This indicates that for successful phage therapy, a cocktail of multiple phages would be necessary to treat Klebsiella infections.

History

Citation

PHAGE, 2 (1), 2021.pp.26-42.http://doi.org/10.1089/phage.2020.0046

Author affiliation

Department of Genetics and Genome Biology

Version

  • VoR (Version of Record)

Published in

Phage

Volume

2

Issue

1

Pagination

26 - 42

Publisher

Mary Ann Liebert, Inc

issn

2641-6530

eissn

2641-6549

Copyright date

2021

Available date

2021-05-10

Spatial coverage

United States

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC